MA
NEO icon

MCF Advisors’s NeoGenomics NEO Stock Holding History

MCF Advisors’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-363
Closed -$5.98K – 987
2024
Q4 		$5.98K Hold
363
– – ﹤0.01% 740
2024
Q3 		$5.36K Hold
363
– – ﹤0.01% 739
2024
Q2 		$5.04K Sell
363
-43
-11% -$610 ﹤0.01% 731
2024
Q1 		$6.38K Hold
406
– – ﹤0.01% 678
2023
Q4 		$6.57K Buy
406
+119
+41% +$1.95K ﹤0.01% 643
2023
Q3 		$3.53K Buy
+287
New +$4.27K ﹤0.01% 698

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

MCF Advisors's NEO Position: Q1 2025 in Review

MCF Advisors sold out of NeoGenomics (NEO) in Q1 2025, closing a stake of 363 shares — an estimated $5.98K sold.

MCF Advisors first reported a position in NEO in Q3 2023 and held it in 6 quarters. The position peaked at $6.57K in Q4 2023. 256 funds tracked by Wall St. Rank hold NEO as of Q1 2025.

  • MCF Advisors reported no remaining NeoGenomics position as of Q1 2025 after selling out during the quarter.
  • MCF Advisors sold 363 NeoGenomics shares in Q1 2025, an estimated $5.98K.
  • MCF Advisors first reported a position in NeoGenomics in Q3 2023 and held it in 6 quarters.
  • MCF Advisors's NeoGenomics position peaked at $6.57K in Q4 2023.
  • 256 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2025.

Based on MCF Advisors's 13F filing for Q1 2025, filed 6 May 2025.